Arkolith/Insider Trading/HUMA/Form 4

Scheessele William John

Chief Commercial OfficerHumacyte, Inc. (HUMA) · full profile →Form 4 · filed Apr 15, 2025
Net Buying
Open-Market Buys
$10K
Open-Market Sells
$0
Net Open-Market Flow
$10K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 14, 2025Buy(P)6K$1.54$10K22K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001818382-25-000052) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML